Related Experiment Videos
Recurrence of pyoderma gangrenosum within a chronic wound following microvascular free-tissue transfer
S S Jejurikar1, W M Kuzon, P S Cederna
1Department of Surgery, University of Michigan Health Systems, Ann Arbor 48109-0340, USA.
Abstract:
The authors present a 29-year-old woman with a chronic foot wound that failed to heal, despite extensive medical and surgical therapy. The diagnosis of pyoderma gangrenosum was ultimately made, and the patient was started on systemic cyclosporine therapy. In the absence of apparent active disease, surgical debridement and microvascular free flap reconstruction were performed to achieve wound closure. Six weeks postoperatively, recurrence of the pyoderma gangrenosum was identified in the free flap, resulting in partial, superficial, flap necrosis. Laboratory evaluation at that time demonstrated subtherapeutic cyclosporine levels. Once the cyclosporine level was increased to the therapeutic range, the wound healed, and the microvascular free flap was salvaged. Because of the relative lack of precision in both the clinical and pathologic determination of acuity level, as well as the tendency toward pathergy, surgical treatment of any form poses many potential risks for these patients. For this reason, surgery should serve only as an adjunct to medical therapy, which remains the mainstay for treatment of pyoderma gangrenosum.
Insights
Pyoderma gangrenosum (PG) recurrence in a microvascular free flap highlights the critical role of maintaining therapeutic cyclosporine levels. Optimal medical management is essential for healing and salvaging surgical reconstructions in PG patients.
Area of Science:
- Dermatology
- Plastic Surgery
- Wound Healing
Background:
- Pyoderma gangrenosum (PG) is a rare, ulcerative inflammatory skin condition.
- Chronic wounds, like the foot ulcer presented, often pose significant treatment challenges.
Observation:
- A 29-year-old female patient with a chronic foot wound refractory to treatment was diagnosed with PG.
- Despite initial medical and surgical interventions, including a microvascular free flap, PG recurred, causing flap necrosis.
Findings:
- Recurrence was linked to subtherapeutic cyclosporine levels.
- Increasing cyclosporine to a therapeutic range led to wound healing and successful flap salvage.
Implications:
- Surgery for PG carries risks due to potential pathergy and diagnostic challenges.
- Systemic immunosuppression, particularly maintaining adequate cyclosporine levels, is crucial for managing PG and preventing recurrence.
- Medical therapy should be the primary treatment modality for pyoderma gangrenosum, with surgery as an adjunct.